img

Global Parkinson's Disease Therapeutics Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Parkinson's Disease Therapeutics Market Insights, Forecast to 2034

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced stages of the disease.
Market Analysis and InsightsGlobal Parkinson's Disease Therapeutics Market
Global Parkinson's Disease Therapeutics market is expected to reach to US$ 2640.6 million in 2023, with a positive growth of %, compared with US$ 2415 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Parkinson's Disease Therapeutics industry is evaluated to reach US$ 3745.7 million in 2033. The CAGR will be 6.0% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Parkinson's Disease Therapeutics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Parkinson's Disease Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Roche
H.Lundbeck
Bausch Health
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Desitin Arzneimittel
Endo Pharmaceuticals
Segment by Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other

Segment by Application


Under 40 Years Old
40-65 Years Old
Above 65 Years Old
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Parkinson's Disease Therapeutics introduction, etc. Parkinson's Disease Therapeutics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Parkinson's Disease Therapeutics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market by Application
1.3.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Therapeutics Market Perspective (2018-2033)
2.2 Global Parkinson's Disease Therapeutics Growth Trends by Region
2.2.1 Parkinson's Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Parkinson's Disease Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Parkinson's Disease Therapeutics Market Dynamics
2.3.1 Parkinson's Disease Therapeutics Industry Trends
2.3.2 Parkinson's Disease Therapeutics Market Drivers
2.3.3 Parkinson's Disease Therapeutics Market Challenges
2.3.4 Parkinson's Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Parkinson's Disease Therapeutics by Players
3.1.1 Global Parkinson's Disease Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Parkinson's Disease Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2022
3.5 Global Key Players of Parkinson's Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Parkinson's Disease Therapeutics, Product and Application
3.7 Global Key Players of Parkinson's Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2024-2033)
5 Parkinson's Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Parkinson's Disease Therapeutics Market Size (2018-2033)
6.2 North America Parkinson's Disease Therapeutics Market Size by Type
6.2.1 North America Parkinson's Disease Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Parkinson's Disease Therapeutics Market Size by Type (2024-2033)
6.2.3 North America Parkinson's Disease Therapeutics Market Share by Type (2018-2033)
6.3 North America Parkinson's Disease Therapeutics Market Size by Application
6.3.1 North America Parkinson's Disease Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Parkinson's Disease Therapeutics Market Size by Application (2024-2033)
6.3.3 North America Parkinson's Disease Therapeutics Market Share by Application (2018-2033)
6.4 North America Parkinson's Disease Therapeutics Market Size by Country
6.4.1 North America Parkinson's Disease Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Parkinson's Disease Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Parkinson's Disease Therapeutics Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Parkinson's Disease Therapeutics Market Size (2018-2033)
7.2 Europe Parkinson's Disease Therapeutics Market Size by Type
7.2.1 Europe Parkinson's Disease Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Parkinson's Disease Therapeutics Market Size by Type (2024-2033)
7.2.3 Europe Parkinson's Disease Therapeutics Market Share by Type (2018-2033)
7.3 Europe Parkinson's Disease Therapeutics Market Size by Application
7.3.1 Europe Parkinson's Disease Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Parkinson's Disease Therapeutics Market Size by Application (2024-2033)
7.3.3 Europe Parkinson's Disease Therapeutics Market Share by Application (2018-2033)
7.4 Europe Parkinson's Disease Therapeutics Market Size by Country
7.4.1 Europe Parkinson's Disease Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Parkinson's Disease Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Parkinson's Disease Therapeutics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Parkinson's Disease Therapeutics Market Size (2018-2033)
8.2 China Parkinson's Disease Therapeutics Market Size by Type
8.2.1 China Parkinson's Disease Therapeutics Market Size by Type (2018-2023)
8.2.2 China Parkinson's Disease Therapeutics Market Size by Type (2024-2033)
8.2.3 China Parkinson's Disease Therapeutics Market Share by Type (2018-2033)
8.3 China Parkinson's Disease Therapeutics Market Size by Application
8.3.1 China Parkinson's Disease Therapeutics Market Size by Application (2018-2023)
8.3.2 China Parkinson's Disease Therapeutics Market Size by Application (2024-2033)
8.3.3 China Parkinson's Disease Therapeutics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Parkinson's Disease Therapeutics Market Size (2018-2033)
9.2 Asia Parkinson's Disease Therapeutics Market Size by Type
9.2.1 Asia Parkinson's Disease Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Parkinson's Disease Therapeutics Market Size by Type (2024-2033)
9.2.3 Asia Parkinson's Disease Therapeutics Market Share by Type (2018-2033)
9.3 Asia Parkinson's Disease Therapeutics Market Size by Application
9.3.1 Asia Parkinson's Disease Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Parkinson's Disease Therapeutics Market Size by Application (2024-2033)
9.3.3 Asia Parkinson's Disease Therapeutics Market Share by Application (2018-2033)
9.4 Asia Parkinson's Disease Therapeutics Market Size by Region
9.4.1 Asia Parkinson's Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Parkinson's Disease Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Parkinson's Disease Therapeutics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson's Disease Therapeutics Introduction
11.1.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.1.5 Merck Recent Developments
11.2 Akorn
11.2.1 Akorn Company Details
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson's Disease Therapeutics Introduction
11.2.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.2.5 Akorn Recent Developments
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson's Disease Therapeutics Introduction
11.3.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.3.5 GSK Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson's Disease Therapeutics Introduction
11.4.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.6.5 Teva Pharmaceutical Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson's Disease Therapeutics Introduction
11.7.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.7.5 Abbvie Recent Developments
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.8.5 Kyowa Hakko Kirin Pharma Recent Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
11.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.9.5 Astellas Pharma Recent Developments
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Parkinson's Disease Therapeutics Introduction
11.10.4 Roche Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.10.5 Roche Recent Developments
11.11 H.Lundbeck
11.11.1 H.Lundbeck Company Details
11.11.2 H.Lundbeck Business Overview
11.11.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
11.11.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.11.5 H.Lundbeck Recent Developments
11.12 Bausch Health
11.12.1 Bausch Health Company Details
11.12.2 Bausch Health Business Overview
11.12.3 Bausch Health Parkinson's Disease Therapeutics Introduction
11.12.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.12.5 Bausch Health Recent Developments
11.13 Apokyn
11.13.1 Apokyn Company Details
11.13.2 Apokyn Business Overview
11.13.3 Apokyn Parkinson's Disease Therapeutics Introduction
11.13.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.13.5 Apokyn Recent Developments
11.14 Orion
11.14.1 Orion Company Details
11.14.2 Orion Business Overview
11.14.3 Orion Parkinson's Disease Therapeutics Introduction
11.14.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.14.5 Orion Recent Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Details
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
11.15.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.15.5 Stada Arzneimittel Recent Developments
11.16 US WorldMeds
11.16.1 US WorldMeds Company Details
11.16.2 US WorldMeds Business Overview
11.16.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
11.16.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.16.5 US WorldMeds Recent Developments
11.17 Desitin Arzneimittel
11.17.1 Desitin Arzneimittel Company Details
11.17.2 Desitin Arzneimittel Business Overview
11.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
11.17.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.17.5 Desitin Arzneimittel Recent Developments
11.18 Endo Pharmaceuticals
11.18.1 Endo Pharmaceuticals Company Details
11.18.2 Endo Pharmaceuticals Business Overview
11.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
11.18.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2018-2023)
11.18.5 Endo Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Trastal
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Other
Table 7. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Parkinson's Disease Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Parkinson's Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Parkinson's Disease Therapeutics Market Share by Region (2018-2023)
Table 11. Global Parkinson's Disease Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Parkinson's Disease Therapeutics Market Share by Region (2024-2033)
Table 13. Parkinson's Disease Therapeutics Market Trends
Table 14. Parkinson's Disease Therapeutics Market Drivers
Table 15. Parkinson's Disease Therapeutics Market Challenges
Table 16. Parkinson's Disease Therapeutics Market Restraints
Table 17. Global Parkinson's Disease Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Parkinson's Disease Therapeutics Revenue Share by Players (2018-2023)
Table 19. Global Top Parkinson's Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2022)
Table 20. Global Parkinson's Disease Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Parkinson's Disease Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Parkinson's Disease Therapeutics, Headquarters and Area Served
Table 23. Global Key Players of Parkinson's Disease Therapeutics, Product and Application
Table 24. Global Key Players of Parkinson's Disease Therapeutics, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinson's Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2018-2023)
Table 28. Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2024-2033)
Table 30. Global Parkinson's Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Parkinson's Disease Therapeutics Revenue Share by Application (2018-2023)
Table 32. Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Parkinson's Disease Therapeutics Revenue Share by Application (2024-2033)
Table 34. North America Parkinson's Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Parkinson's Disease Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Parkinson's Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Parkinson's Disease Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Parkinson's Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Parkinson's Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Parkinson's Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Parkinson's Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Parkinson's Disease Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Parkinson's Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Parkinson's Disease Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Parkinson's Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Parkinson's Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Parkinson's Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Parkinson's Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Parkinson's Disease Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Parkinson's Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Parkinson's Disease Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Parkinson's Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Parkinson's Disease Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Parkinson's Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Parkinson's Disease Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Parkinson's Disease Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Parkinson's Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Parkinson's Disease Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Parkinson's Disease Therapeutics Product
Table 69. Merck Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Merck Recent Developments
Table 71. Akorn Company Details
Table 72. Akorn Business Overview
Table 73. Akorn Parkinson's Disease Therapeutics Product
Table 74. Akorn Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Akorn Recent Developments
Table 76. GSK Company Details
Table 77. GSK Business Overview
Table 78. GSK Parkinson's Disease Therapeutics Product
Table 79. GSK Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 80. GSK Recent Developments
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Parkinson's Disease Therapeutics Product
Table 84. Novartis Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 85. Novartis Recent Developments
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Parkinson's Disease Therapeutics Product
Table 89. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Developments
Table 91. Teva Pharmaceutical Company Details
Table 92. Teva Pharmaceutical Business Overview
Table 93. Teva Pharmaceutical Parkinson's Disease Therapeutics Product
Table 94. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 95. Teva Pharmaceutical Recent Developments
Table 96. Abbvie Company Details
Table 97. Abbvie Business Overview
Table 98. Abbvie Parkinson's Disease Therapeutics Product
Table 99. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 100. Abbvie Recent Developments
Table 101. Kyowa Hakko Kirin Pharma Company Details
Table 102. Kyowa Hakko Kirin Pharma Business Overview
Table 103. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product
Table 104. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 105. Kyowa Hakko Kirin Pharma Recent Developments
Table 106. Astellas Pharma Company Details
Table 107. Astellas Pharma Business Overview
Table 108. Astellas Pharma Parkinson's Disease Therapeutics Product
Table 109. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 110. Astellas Pharma Recent Developments
Table 111. Roche Company Details
Table 112. Roche Business Overview
Table 113. Roche Parkinson's Disease Therapeutics Product
Table 114. Roche Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 115. Roche Recent Developments
Table 116. H.Lundbeck Company Details
Table 117. H.Lundbeck Business Overview
Table 118. H.Lundbeck Parkinson's Disease Therapeutics Product
Table 119. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 120. H.Lundbeck Recent Developments
Table 121. Bausch Health Company Details
Table 122. Bausch Health Business Overview
Table 123. Bausch Health Parkinson's Disease Therapeutics Product
Table 124. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 125. Bausch Health Recent Developments
Table 126. Apokyn Company Details
Table 127. Apokyn Business Overview
Table 128. Apokyn Parkinson's Disease Therapeutics Product
Table 129. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 130. Apokyn Recent Developments
Table 131. Orion Company Details
Table 132. Orion Business Overview
Table 133. Orion Parkinson's Disease Therapeutics Product
Table 134. Orion Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 135. Orion Recent Developments
Table 136. Stada Arzneimittel Company Details
Table 137. Stada Arzneimittel Business Overview
Table 138. Stada Arzneimittel Parkinson's Disease Therapeutics Product
Table 139. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 140. Stada Arzneimittel Recent Developments
Table 141. US WorldMeds Company Details
Table 142. US WorldMeds Business Overview
Table 143. US WorldMeds Parkinson's Disease Therapeutics Product
Table 144. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 145. US WorldMeds Recent Developments
Table 146. Desitin Arzneimittel Company Details
Table 147. Desitin Arzneimittel Business Overview
Table 148. Desitin Arzneimittel Parkinson's Disease Therapeutics Product
Table 149. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 150. Desitin Arzneimittel Recent Developments
Table 151. Endo Pharmaceuticals Company Details
Table 152. Endo Pharmaceuticals Business Overview
Table 153. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product
Table 154. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 155. Endo Pharmaceuticals Recent Developments
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Parkinson's Disease Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Sinemet-CR Features
Figure 4. Trastal Features
Figure 5. Madopar Features
Figure 6. COMT Inhibitor Features
Figure 7. Other Features
Figure 8. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Parkinson's Disease Therapeutics Market Share by Application: 2022 VS 2033
Figure 10. Under 40 Years Old Case Studies
Figure 11. 40-65 Years Old Case Studies
Figure 12. Above 65 Years Old Case Studies
Figure 13. Parkinson's Disease Therapeutics Report Years Considered
Figure 14. Global Parkinson's Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Parkinson's Disease Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Parkinson's Disease Therapeutics Market Share by Region: 2022 VS 2033
Figure 17. Global Parkinson's Disease Therapeutics Market Share by Players in 2022
Figure 18. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2022
Figure 20. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Parkinson's Disease Therapeutics Market Share by Type (2018-2033)
Figure 22. North America Parkinson's Disease Therapeutics Market Share by Application (2018-2033)
Figure 23. North America Parkinson's Disease Therapeutics Market Share by Country (2018-2033)
Figure 24. United States Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Parkinson's Disease Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Parkinson's Disease Therapeutics Market Share by Type (2018-2033)
Figure 28. Europe Parkinson's Disease Therapeutics Market Share by Application (2018-2033)
Figure 29. Europe Parkinson's Disease Therapeutics Market Share by Country (2018-2033)
Figure 30. Germany Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Parkinson's Disease Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Parkinson's Disease Therapeutics Market Share by Type (2018-2033)
Figure 38. China Parkinson's Disease Therapeutics Market Share by Application (2018-2033)
Figure 39. Asia Parkinson's Disease Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Parkinson's Disease Therapeutics Market Share by Type (2018-2033)
Figure 41. Asia Parkinson's Disease Therapeutics Market Share by Application (2018-2033)
Figure 42. Asia Parkinson's Disease Therapeutics Market Share by Region (2018-2033)
Figure 43. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Parkinson's Disease Therapeutics Market Share by Country (2018-2033)
Figure 53. Brazil Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Parkinson's Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 60. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 61. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 62. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 65. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 66. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 67. Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 68. Roche Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 69. H.Lundbeck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 70. Bausch Health Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 71. Apokyn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 72. Orion Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 73. Stada Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 74. US WorldMeds Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 75. Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 76. Endo Pharmaceuticals Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed